
Learn how Gibco™ Rapid Prototyping can help idenitfy the most feasible cell culture media for cGMP scale-up.

Learn how Gibco™ Rapid Prototyping can help idenitfy the most feasible cell culture media for cGMP scale-up.



This session will address ways to help streamline media manufacturing, including rapid, small-scale non-cGMP media prototyping and proprietary media formulation outsourcing options.

Learn how Gibco™ Rapid Prototyping can accelerate your journey to cGMP





In this brochure, learn about the Eppendorf Centrifuge CR22N and CR30NX, the everyday centrifuges perfect for a wide range of applications. Read about unique features, technical specifications, common rotor options and more.

This application note describes production of a recombinant protein using a workflow for culturing and harvesting bacteria and purifying proteins. The Eppendorf Centrifuge CR22N or CR30NX is used in combination with the Innova S44i Shaker for a high yield of functional recombinant protein.

This white paper introduces a method for reducing harvesting time of yeast, bacteria, or cell cultures by up to 32% using the Eppendorf Centrifuge CR22N or CR30NX with unique triangular 1.5 L bottles.

This white paper highlights Pharma’s data integrity challenge and its impact on manufacturing, and proposes solutions for Pharma’s successful digital transformation journey.





In this industry brief, we examine key challenges that exist in the biopharma industry, particularly in the early phases of commercialization, and review ways organizations can address them.

Moving a biopharmaceutical product from molecule-to-market is demanding in terms of expertise and capabilities needed throughout the development and manufacturing process. In this white paper, we explore the processes, operations, and customer-focused approach of Emergent CDMO's integrated internal teams, providing efficient organization alongside smooth and timely technology transfer and scale-up, from R&D to GMP manufacturing. Download our latest white paper to learn how partnering with an integrated CDMO can help create an efficient development services framework to achieve your drug substance and drug product manufacturing goals.



This article presents a detailed mapping of processes and data flow to identify the gaps associated to Data Integrity for GxP processes managed by computerized system and/or manually.



This application demonstrates the advantage of coupling LC-MS to a HPLC-UV system for highly sensitive (pg level) and selective quantitative analysis in cleaning validation.

Understand the role proper wiping technique plays in relaiable and consistent contamination control. Review the right way to quarterfold a wipe as well as the correct technique when wiping a surface to ensure contamination removal.


Patient recruitment, retention, diversity, & safety are all factors driving the need for radical innovation in clinical research. This need was made painfully apparent during the current COVID-19 pandemic. We can no longer ‘do the same thing and expect a different result’; it’s time to take giant steps forward. Find out how Medable, the recognized industry leaders in Decentralized Clinical trials, can partner with your organization to digitally transform your clinical protocols. Your research teams can experience benefits such as; improved patient experience, higher quality outcomes data, & savings of US$25,000,000+ for individual studies. Download the White Paper now.

Over 70% of potential research participants live >2 hours away from a research site, & patient drop-out rates can reach 30% depending on the therapeutic area. The Solution: Medable eConsent Why? 1. Medable eConsent enables the enrollment of underrepresented, diverse populations through remote consenting. 2. Medable eConsent has proven to reduce screening timelines by 50%, & increase patient engagement by 15%+.

A recent study by Morning Consult finds that >54% of US adults would be willing to participate in a clinical trial if it had a 30-minute-or-less commute. This is quite striking, given that <4% of the 328 million people in America are actively participating in clinical research today. The solution? - An accessible, intuitive digital clinical platform that connects sponsors, sites & patients, and replaces burdensome paper forms and physical visits with electronic consents (eConsent), electronic Clinical Outcome Assessments (eCOA’s), and remote visits (TeleVisits). Find out how Medable, the recognized industry leaders in Decentralized Clinical trials, can partner with your organization to digitally transform your clinical protocols. Your research teams can experience benefits such as; improved patient experience, higher quality outcomes data, & savings of US$25,000,000+ for individual studies. Download the White Paper now to learn how.